Evans, Ben E.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Evans, Ben E..The latest application filed is for "dihydropyrimidines and uses thereof".
- Evans, Ben E. - Lansdale PA
- Evans; Ben E. - Landsdale PA
| Patent | Date |
|---|---|
| Dihydropyrimidines and uses thereof App 20040138242 - Cui, Donghui ; et al. | 2004-07-15 |
| Dihydropyrimidines and uses thereof Grant 6,680,323 - Cui , et al. January 20, 2 | 2004-01-20 |
| Spirotricyclic substituted azacycloalkane derivatives and uses thereof Grant 6,387,893 - Evans , et al. May 14, 2 | 2002-05-14 |
| Dihydropyrimidines and uses thereof App 20010041707 - Cui, Donghui ; et al. | 2001-11-15 |
| Dihydropyrimidines and uses thereof Grant 6,274,585 - Cui , et al. August 14, 2 | 2001-08-14 |
| Tocolytic oxytocin receptor antagonists Grant 5,756,504 - Bock , et al. May 26, 1 | 1998-05-26 |
| Hydantoin and succinimide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists Grant 5,693,643 - Gilbert , et al. December 2, 1 | 1997-12-02 |
| Tocolytic oxytocin receptor antagonists Grant 5,670,509 - Evans , et al. September 23, 1 | 1997-09-23 |
| Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists Grant 5,665,719 - Bock , et al. September 9, 1 | 1997-09-09 |
| Tocolytic oxytocin receptor antagonists Grant 5,464,788 - Bock , et al. November 7, 1 | 1995-11-07 |
| Benzodiazepine analogs Grant 5,324,726 - Bock , et al. June 28, 1 | 1994-06-28 |
| Benzolactam analogs as antagonists of CCK Grant 5,206,234 - Bock , et al. April 27, 1 | 1993-04-27 |
| Benzodiazepine analogs Grant 5,206,237 - Freidinger , et al. April 27, 1 | 1993-04-27 |
| Amide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists Grant 5,204,349 - Bock , et al. April 20, 1 | 1993-04-20 |
| Triazolobenzodiazepines Grant 5,185,331 - Freidinger , et al. February 9, 1 | 1993-02-09 |
| 1,4-benzodiazepines with 6-membered heterocyclic rings to treat panic and anxiety disorder Grant 5,177,071 - Freidinger , et al. January 5, 1 | 1993-01-05 |
| 3-substituted-1,4-benzodiazepines as oxytocin antagonists Grant 5,175,159 - Bock , et al. December 29, 1 | 1992-12-29 |
| 2-Benzazepines with 5- and 6-membered heterocyclic rings, compositions and medical methods of use thereof Grant 5,166,151 - Freidinger , et al. November 24, 1 | 1992-11-24 |
| Spirocyclic oxytocin antagonists Grant 5,091,387 - Evans , et al. February 25, 1 | 1992-02-25 |
| Methods of antagonizing CCK or gastrin with benzodiazepine analogs Grant 5,004,741 - Evans , et al. April 2, 1 | 1991-04-02 |
| Benzodiazepine analogs Grant 4,820,834 - Evans , et al. April 11, 1 | 1989-04-11 |
| Tripeptide renin inhibitors Grant 4,812,442 - Boger , et al. March 14, 1 | 1989-03-14 |
| Benzodiazepine analogs and use as antogonists of gastrin and cholecystokinin Grant 4,755,508 - Bock , et al. July 5, 1 | 1988-07-05 |
| 2-acylaminomethyl-1,4-benzodiazepine derivatives as CCK-antagonists Grant 4,684,646 - Chang , et al. August 4, 1 | 1987-08-04 |
| Renin inhibitory tripeptides Grant 4,668,770 - Boger , et al. May 26, 1 | 1987-05-26 |
| Triazolobenzodiazepines and pharmaceutical use Grant 4,663,321 - Bock , et al. May 5, 1 | 1987-05-05 |
| Renin inhibitory peptides having improved solubility Grant 4,636,491 - Bock , et al. January 13, 1 | 1987-01-13 |
| Renin-inhibitory peptide analogs Grant 4,609,641 - Evans , et al. September 2, 1 | 1986-09-02 |
| Method of preparing statine and derivatives Grant 4,397,786 - Evans , et al. August 9, 1 | 1983-08-09 |
| Dibenzo[a,d]cycloocten-5,12-(and 6,12)-imines Grant 4,374,838 - Anderson , et al. February 22, 1 | 1983-02-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 